Journey Medical Corporation (DERM) Revenue Growth
Journey Medical Corporation (DERM) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 12.45% |
| 2023-12-31 | -15.96% |
| 2024-12-31 | -7.59% |
| 2025-12-31 | 11.07% |
How DERM compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| INNV | InnovAge Holding Corp. | 11.76% |
| EW | Edwards Lifesciences Corporation | 11.55% |
| RDNT | RadNet Inc. | 11.51% |
| NEO | NeoGenomics Inc. | 10.11% |
| ABBV | AbbVie Inc. | 8.57% |
These are five companies in the same sector as DERM with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Journey Medical Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("DERM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DERM | $7.41 | -0.80% | 0.07M |
| 3 | ||||
| 4 | ||||
| 5 |